Viravarn Luvira

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

William HK Schilling, Podjanee Jittamala, James A Watson et al. · The Lancet Infectious Diseases · 2023 · 85 citations · Full text

Comparative Diagnosis of Strongyloidiasis in Immunocompromised Patients

Viravarn Luvira, Kitti Trakulhun, Mathirut Mungthin et al. · American Journal of Tropical Medicine and Hygiene · 2016 · 80 citations · Full text

Parasitic Disease, Strongyloides Hyperinfection Syndrome, Malaria +17

Etiologies of Acute Undifferentiated Febrile Illness in Bangkok, Thailand

Viravarn Luvira, Udomsak Silachamroon, Watcharapong Piyaphanee et al. · American Journal of Tropical Medicine and Hygiene · 2019 · 65 citations · Full text

Distinct amino acid and lipid perturbations characterize acute versus chronic malaria

Regina Joice Cordy, Rapatbhorn Patrapuvich, Loukia N. Lili et al. · JCI Insight · 2019 · 58 citations · Full text

Metabolic Syndrome, Lipid Perturbations, Biochemistry +14

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri et al. · EClinicalMedicine · 2022 · 54 citations · Full text